The SF3B1 gene is mutated in 3.6%-9.3% of patients with newly diagnosed CLL, which increases to 17% at relapse, and is enriched in patients with subset 2 disease[34]. The gene discussed is SF3B1; the disease is B-cell chronic lymphocytic leukemia.